Top

11-23-2016 | Specific populations | Book chapter | Article

14. Diabetes in Native Populations and Underserved Communities in the USA

Authors: Joshua J. Joseph, MD, Sherita Hill Golden, MD, MHS

Publisher: Springer International Publishing

Abstract

In the USA type 2 diabetes mellitus affects roughly 9 % of the population with a disproportionate burden in racial/ethnic minorities. The prevalence of diabetes is highest in American Indians/Native Alaskans followed by non-Hispanic blacks, Hispanic Americans, Asian Americans, and non-Hispanic whites. Many causes exist for the disparity in rates of prevalent diabetes spanning from biology and genetics to healthcare delivery and prevention programs for diabetes. Racial/ethnic minorities also have higher rates of microvascular complications suggesting a need for examination of delivery of care, non-pharmacological treatment, and selection of antidiabetes medications. In this article we review the epidemiology, classification, and unique pathophysiological aspects of type 2 diabetes in minority populations in the USA including race/ethnic differences in biological factors (obesity, fat distribution, glucose metabolism, and insulin resistance) and nonbiological factors (acculturation and health behaviors). We evaluate the genomic and epigenetic landscape including novel diabetes-associated single nucleotide polymorphisms (SNPs) and epigenetic factors specific to native populations and underserved communities. We assess the limitations of current diagnostic criteria including racial/ethnic differences in hemoglobin A1c. We examine issues related to management of diabetes in native and underserved populations from a multilevel perspective, beginning with the coordination and delivery of diabetes care services progressing to pharmacologic and non-pharmacological management of diabetes, including lifestyle and surgical interventions. Last, we evaluate the current models of translation of primary prevention of diabetes in native and underserved populations and finish with a discussion of unmet research needs. In this manner we aim to provide a comprehensive review of important aspects of diabetes and its management in native populations and underserved communities.

Golden SH, Brown A, Cauley JA, Chin MH, Gary-Webb TL, Kim C, et al. Health disparities in endocrine disorders: biological, clinical, and nonclinical factors – an Endocrine Society scientific statement. J Clin Endocrinol Metab. 2012;97(9):E1579–639.PubMedPubMedCentralCrossRef

Daviglus ML, Talavera GA, Avilés-Santa ML, Allison M, Cai J, Criqui MH, et al. Prevalence of major cardiovascular risk factors and cardiovascular diseases among Hispanic/Latino individuals of diverse backgrounds in the United States. JAMA. 2012;308(17):1775.PubMedPubMedCentralCrossRef

Geiss LS, Wang J, Cheng YJ, Thompson TJ, Barker L, Li Y, et al. Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980–2012. JAMA. 2014;312(12):1218.PubMedCrossRef

Narayan KMV, Aviles-Santa L, Oza-Frank R, Pandey M, Curb JD, McNeely M, et al. Report of a National Heart, Lung, And Blood Institute Workshop: heterogeneity in cardiometabolic risk in Asian Americans in the U.S. Opportunities for research. J Am Coll Cardiol. 2010;55(10):966–73.PubMedCrossRef

Chien AT, Chin MH, Davis AM, Casalino LP. Pay for performance, public reporting, and racial disparities in health care: how are programs being designed? Med Care Res Rev MCRR. 2007;64(5 Suppl):283S–304.PubMedCrossRef

Karter AJ, Schillinger D, Adams AS, Moffet HH, Liu J, Adler NE, et al. Elevated rates of diabetes in Pacific Islanders and Asian subgroups: the Diabetes Study of Northern California (DISTANCE). Diabetes Care. 2013;36(3):574–9.PubMedPubMedCentralCrossRef

Dagogo-Jack S. Ethnic disparities in type 2 diabetes: pathophysiology and implications for prevention and management. J Natl Med Assoc. 2003;95(9):774. 779–89.PubMedPubMedCentral

Torrens J. Ethnic differences in insulin sensitivity and beta-cell function in premenopausal or early perimenopausal women without diabetes: the Study of Women’s Health Across the Nation (SWAN). Diabetes Care. 2004;27(2 SRC - GoogleScholar):354–61.PubMedCrossRef

Perez-Escamilla RJ. Acculturation, nutrition, and health disparities in Latinos. Am Nutr P S. 2011;93(5 SRC - GoogleScholar):1163S–7.

10.

Kurian AK, Cardarelli KM. Racial and ethnic differences in cardiovascular disease risk factors: a systematic review. Ethn Dis. 2007;17(1):143–52.PubMed

11.

McCarthy MI. Genomics, type 2 diabetes, and obesity. N Engl J Med. 2010;363(24):2339–50.PubMedCrossRef

12.

Kooner JS, Saleheen D, Sim X, Sehmi J, Zhang W, Frossard P, et al. Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci. Nat Genet. 2011;43(10):984–9.PubMedPubMedCentralCrossRef

13.

Cho YS, Chen C-H, Hu C, Long J, Hee Ong RT, Sim X, et al. Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians. Nat Genet. 2011;44(1):67–72.PubMedPubMedCentralCrossRef

14.

Palmer ND, McDonough CW, Hicks PJ, Roh BH, Wing MR, An SS, et al. A genome-wide association search for type 2 diabetes genes in African Americans. PLoS One. 2012;7(1):e29202.PubMedPubMedCentralCrossRef

15.

Kuzawa CW, Sweet E. Epigenetics and the embodiment of race: developmental origins of US racial disparities in cardiovascular health. Am J Hum Biol Off J Hum Biol Counc. 2009;21(1):2–15.CrossRef

16.

Anagnostis P, Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP. The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. J Clin Endocrinol Metab. 2009;94(8):2692–701.PubMedCrossRef

17.

Slomko H, Heo HJ, Einstein FH. Minireview: epigenetics of obesity and diabetes in humans. Endocrinology. 2012;153(3):1025–30.PubMedPubMedCentralCrossRef

18.

Dagogo-Jack S. Pitfalls in the use of HbA₁(c) as a diagnostic test: the ethnic conundrum. Nat Rev Endocrinol. 2010;6(10):589–93.PubMed

19.

Ziemer DC, Kolm P, Weintraub WS, Vaccarino V, Rhee MK, Twombly JG, et al. Glucose-independent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies. Ann Intern Med. 2010;152(12):770–7.PubMedCrossRef

20.

Selvin E, Steffes MW, Ballantyne CM, Hoogeveen RC, Coresh J, Brancati FL. Racial differences in glycemic markers: a cross-sectional analysis of community-based data. Ann Intern Med. 2011;154(5):303–9.PubMedPubMedCentralCrossRef

21.

Minority H. Office of Office of Minority Health. 2012.

22.

Kirk JK, Bell RA, Bertoni AG, Arcury TA, Quandt SA, Goff DC, et al. Ethnic disparities: control of glycemia, blood pressure, and LDL cholesterol among US adults with type 2 diabetes. Ann Pharmacother. 2005;39(9):1489–501.PubMedCrossRef

23.

Kirk JK. Disparities in HbA1c levels between African-American and Non-Hispanic white adults with diabetes: a meta-analysis. Diabetes Care. 2006;29(9):2130–6.PubMedPubMedCentralCrossRef

24.

Kirk JK, Passmore LV, Bell RA, Narayan K, D’Agostino RB, Arcury TA, et al. Disparities in A1c levels between Hispanic and non-Hispanic White adults with diabetes. Diabetes Care. 2008;31(2):240.PubMedCrossRef

25.

Selvin E, Ning Y, Steffes MW, Bash LD, Klein R, Wong TY, et al. Glycated hemoglobin and the risk of kidney disease and retinopathy in adults with and without diabetes. Diabetes. 2011;60(1):298–305.PubMedCrossRef

26.

Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, Pankow J, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med. 2010;362(9):800–11.PubMedPubMedCentralCrossRef

27.

Matsushita K, Blecker S, Pazin-Filho A, Bertoni A, Chang PP, Coresh J, et al. The association of hemoglobin a1c with incident heart failure among people without diabetes: the atherosclerosis risk in communities study. Diabetes. 2010;59(8):2020–6.PubMedPubMedCentralCrossRef

28.

Lakkis J, Weir MR. Pharmacological strategies for kidney function preservation: are there differences by ethnicity? Adv Ren Replace Ther. 2004;11(1):24–40.PubMedCrossRef

29.

Lopes AA. End-stage renal disease due to diabetes in racial/ethnic minorities and disadvantaged populations. Ethn Dis. 2009;19(1 Suppl 1):S1–47.

30.

Sumner AE, Zhou J, Doumatey A, Imoisili OE, Amoah A, Acheampong J, et al. Low HDL-cholesterol with normal triglyceride levels is the most common lipid pattern in west Africans and African Americans with metabolic syndrome: implications for cardiovascular disease prevention. CVD Prev Control. 2010;5(3):75–80.PubMedPubMedCentralCrossRef

31.

Kirk JK, Graves DE, Bell RA, Hildebrandt CA, Narayan KMV. Racial and ethnic disparities in self-monitoring of blood glucose among US adults: a qualitative review. Ethn Dis. 2007;17(1):135–42.PubMed

32.

Tricco AC, Ivers NM, Grimshaw JM, Moher D, Turner L, Galipeau J, et al. Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis. Lancet Lond Engl. 2012;379(9833):2252–61.CrossRef

33.

Shojania KG, Ranji SR, McDonald KM, Grimshaw JM, Sundaram V, Rushakoff RJ, et al. Effects of quality improvement strategies for type 2 diabetes on glycemic control: a meta-regression analysis. JAMA. 2006;296(4):427–40.PubMedCrossRef

34.

Pimouguet C, Le Goff M, Thiébaut R, Dartigues JF, Helmer C. Effectiveness of disease-management programs for improving diabetes care: a meta-analysis. CMAJ Can Med Assoc J J Assoc Med Can. 2011;183(2):E115–27.CrossRef

35.

Glazier RH, Bajcar J, Kennie NR, Willson K. A systematic review of interventions to improve diabetes care in socially disadvantaged populations. Diabetes Care. 2006;29(7):1675–88.PubMedCrossRef

36.

Davidson MB. Effect of nurse-directed diabetes care in a minority population. Diabetes Care. 2003;26(8):2281–7.PubMedCrossRef

37.

Peek ME, Cargill A, Huang ES. Diabetes health disparities: a systematic review of health care interventions. Med Care Res Rev. 2007;64(5 suppl):101S–56.PubMedPubMedCentralCrossRef

38.

Ricci-Cabello I, Ruiz-Pérez I, Olry de Labry-Lima A, Márquez-Calderón S. Do social inequalities exist in terms of the prevention, diagnosis, treatment, control and monitoring of diabetes? A systematic review. Health Soc Care Community. 2010;18(6):572–87.PubMedCrossRef

39.

Basch CE, Walker EA, Howard CJ, Shamoon H, Zybert P. The effect of health education on the rate of ophthalmic examinations among African Americans with diabetes mellitus. Am J Public Health. 1999;89(12):1878–82.PubMedPubMedCentralCrossRef

40.

Clancy DE, Cope DW, Magruder KM, Huang P, Salter KH, Fields AW. Evaluating group visits in an uninsured or inadequately insured patient population with uncontrolled type 2 diabetes. Diabetes Educ. 2003;29(2):292–302.PubMedCrossRef

41.

Gerber BS, Brodsky IG, Lawless KA, Smolin LI, Arozullah AM, Smith EV, et al. Implementation and evaluation of a low-literacy diabetes education computer multimedia application. Diabetes Care. 2005;28(7):1574–80.PubMedCrossRef

42.

Erdman DM, Cook CB, Greenlund KJ, Giles WH, El-Kebbi I, Ryan GJ, et al. The impact of outpatient diabetes management on serum lipids in urban African-Americans with type 2 diabetes. Diabetes Care. 2002;25(1):9–15.PubMedCrossRef

43.

Ziemer DC, Berkowitz KJ, Panayioto RM, El-Kebbi IM, Musey VC, Anderson LA, et al. A simple meal plan emphasizing healthy food choices is as effective as an exchange-based meal plan for urban African Americans with type 2 diabetes. Diabetes Care. 2003;26(6):1719–24.PubMedCrossRef

44.

Anderson RM, Musch DC, Nwankwo RB, Wolf FM, Gillard ML, Oh MS, et al. Personalized follow-up increases return rate at urban eye disease screening clinics for African Americans with diabetes: results of a randomized trial. Ethn Dis. 2003;13(1):40–6.PubMed

45.

D’Eramo-Melkus G, Spollett G, Jefferson V, Chyun D, Tuohy B, Robinson T, et al. A culturally competent intervention of education and care for black women with type 2 diabetes. Appl Nurs Res ANR. 2004;17(1):10–20.PubMedCrossRef

46.

Tang TS, Gillard ML, Funnell MM, Nwankwo R, Parker E, Spurlock D, et al. Developing a new generation of ongoing: diabetes self-management support interventions: a preliminary report. Diabetes Educ. 2005;31(1):91–7.PubMedCrossRef

47.

Amoako E, Skelly AH, Rossen EK. Outcomes of an intervention to reduce uncertainty among African American women with diabetes. West J Nurs Res. 2008;30(8):928–42.PubMedCrossRef

48.

Skelly AH, Carlson J, Leeman J, Soward A, Burns D. Controlled trial of nursing interventions to improve health outcomes of older African American women with type 2 diabetes. Nurs Res. 2009;58(6):410–8.PubMedPubMedCentralCrossRef

49.

Tang TS, Funnell MM, Brown MB, Kurlander JE. Self-management support in “real-world” settings: an empowerment-based intervention. Patient Educ Couns. 2010;79(2):178–84.PubMedCrossRef

50.

Walker EA, Stevens KA, Persaud S. Promoting diabetes self-management among African Americans: an educational intervention. J Health Care Poor Underserved. 2010;21(3 Suppl):169–86.PubMedCrossRef

51.

Carter EL, Nunlee-Bland G, Callender C. A patient-centric, provider-assisted diabetes telehealth self-management intervention for urban minorities. Perspect Health Inf Manag AHIMA Am Health Inf Manag Assoc. 2011;8:1b.

52.

Ellish NJ, Royak-Schaler R, Higginbotham EJ. Tailored and targeted interventions to encourage dilated fundus examinations in older African Americans. Arch Ophthalmol Chic Ill 1960. 2011;129(12):1592–8.CrossRef

53.

Tang TS, Funnell MM, Noorulla S, Oh M, Brown MB. Sustaining short-term improvements over the long-term: results from a 2-year diabetes self-management support (DSMS) intervention. Diabetes Res Clin Pract. 2012;95(1):85–92.PubMedCrossRef

54.

Agurs-Collins TD, Kumanyika SK, Ten Have TR, Adams-Campbell LL. A randomized controlled trial of weight reduction and exercise for diabetes management in older African-American subjects. Diabetes Care. 1997;20(10):1503–11.PubMedCrossRef

55.

Anderson-Loftin W, Barnett S, Sullivan P, Bunn PS, Tavakoli A. Culturally competent dietary education for southern rural African Americans with diabetes. Diabetes Educ. 2002;28(2):245–57.PubMedCrossRef

56.

Brown SA, Hanis CL. Culturally competent diabetes education for Mexican Americans: the Starr County Study. Diabetes Educ. 1999;25(2):226–36.PubMedCrossRef

57.

Brown SA, Garcia AA, Kouzekanani K, Hanis CL. Culturally competent diabetes self-management education for Mexican Americans: the Starr County border health initiative. Diabetes Care. 2002;25(2):259–68.PubMedPubMedCentralCrossRef

58.

Brown SA, Blozis SA, Kouzekanani K, Garcia AA, Winchell M, Hanis CL. Dosage effects of diabetes self-management education for Mexican Americans: the Starr County Border Health Initiative. Diabetes Care. 2005;28(3):527–32.PubMedPubMedCentralCrossRef

59.

Corkery E, Palmer C, Foley ME, Schechter CB, Frisher L, Roman SH. Effect of a bicultural community health worker on completion of diabetes education in a Hispanic population. Diabetes Care. 1997;20(3):254–7.PubMedCrossRef

60.

Keyserling TC, Samuel-Hodge CD, Ammerman AS, Ainsworth BE, Henríquez-Roldán CF, Elasy TA, et al. A randomized trial of an intervention to improve self-care behaviors of African-American women with type 2 diabetes: impact on physical activity. Diabetes Care. 2002;25(9):1576–83.PubMedCrossRef

61.

Mayer-Davis EJ, D’Antonio A, Martin M, Wandersman A, Parra-Medina D, Schulz R. Pilot study of strategies for effective weight management in type 2 diabetes: Pounds Off with Empowerment (POWER). Fam Community Health. 2001;24(2):27–35.PubMedCrossRef

62.

Mayer-Davis EJ, D’Antonio AM, Smith SM, Kirkner G, Levin Martin S, Parra-Medina D, et al. Pounds off with empowerment (POWER): a clinical trial of weight management strategies for black and white adults with diabetes who live in medically underserved rural communities. Am J Public Health. 2004;94(10):1736–42.PubMedPubMedCentralCrossRef

63.

McNabb WL, Quinn MT, Rosing L. Weight loss program for inner-city black women with non-insulin-dependent diabetes mellitus: PATHWAYS. J Am Diet Assoc. 1993;93(1):75–7.PubMedCrossRef

64.

Rosal MC, Olendzki B, Reed GW, Gumieniak O, Scavron J, Ockene I. Diabetes self-management among low-income Spanish-speaking patients: a pilot study. Ann Behav Med Publ Soc Behav Med. 2005;29(3):225–35.CrossRef

65.

Feathers J. Racial and Ethnic Approaches to Community Health (REACH) detroit partnership: improving diabetes-related outcomes among African American and Latino adults. Am J Publ Health P. 2005;95(9 SRC - GoogleScholar):1552–60.CrossRef

66.

Vazquez IM, Millen B, Bissett L, Levenson SM, Chipkin SR. Buena Alimentacion, Buena Salud: a preventive nutrition intervention in Caribbean Latinos with type 2 diabetes. Am J Health Promot AJHP. 1998;13(2):116–9.PubMedCrossRef

67.

Anderson RM, Funnell MM, Nwankwo R, Gillard ML, Oh M, Fitzgerald JT, et al. Evaluating a problem-based empowerment program for African Americans with diabetes: results of a randomized controlled trial. Ethn Dis. 2005;15(4):671.PubMed

68.

Murrock CJ, Higgins PA, Killion C. Dance and peer support to improve diabetes outcomes in African American women. Diabetes Educ. 2009;35(6):995–1003.PubMedCrossRef

69.

Bogner HR, de Vries HF. Integrating type 2 diabetes mellitus and depression treatment among African Americans: a randomized controlled pilot trial. Diabetes Educ. 2010;36(2):284–92.PubMedCrossRef

70.

D’Eramo MG. The effect of a diabetes education, coping skills training, and care intervention on physiological and psychosocial outcomes in black women with type 2 diabetes. Biol Res Nurs P. 2010;12(1 SRC - GoogleScholar):7–19.CrossRef

71.

Hill-Briggs F, Lazo M, Peyrot M, Doswell A, Chang Y-T, Hill MN, et al. Effect of problem-solving-based diabetes self-management training on diabetes control in a low income patient sample. J Gen Intern Med. 2011;26(9):972–8.PubMedPubMedCentralCrossRef

72.

Benjamin EM, Schneider MS, Hinchey KT. Implementing practice guidelines for diabetes care using problem-based learning. A prospective controlled trial using firm systems. Diabetes Care. 1999;22(10):1672–8.PubMedCrossRef

73.

Din-Dzietham R, Porterfield DS, Cohen SJ, Reaves J, Burrus B, Lamb BM. Quality care improvement program in a community-based participatory research project: example of Project DIRECT. J Natl Med Assoc. 2004;96(10):1310–21.PubMedPubMedCentral

74.

Fox CH, Mahoney MC. Improving diabetes preventive care in a family practice residency program: a case study in continuous quality improvement. Fam Med. 1998;30(6):441–5.PubMed

75.

Phillips LS, Hertzberg VS, Cook CB, El-Kebbi IM, Gallina DL, Ziemer DC, et al. The Improving Primary Care of African Americans with Diabetes (IPCAAD) project: rationale and design. Control Clin Trials. 2002;23(5):554–69.PubMedCrossRef

76.

Phillips LS, Ziemer DC, Doyle JP, Barnes CS, Kolm P, Branch WT, et al. An endocrinologist-supported intervention aimed at providers improves diabetes management in a primary care site: improving primary care of African Americans with diabetes (IPCAAD) 7. Diabetes Care. 2005;28(10):2352–60.PubMedCrossRef

77.

Thaler LM, Ziemer DC, Gallina DL, Cook CB, Dunbar VG, Phillips LS, et al. Diabetes in urban African-Americans. XVII. Availability of rapid HbA1c measurements enhances clinical decision-making. Diabetes Care. 1999;22(9):1415–21.PubMedCrossRef

78.

Ziemer DC, Doyle JP, Barnes CS, Branch WT, Cook CB, El-Kebbi IM, et al. An intervention to overcome clinical inertia and improve diabetes mellitus control in a primary care setting: Improving Primary Care of African Americans with Diabetes (IPCAAD) 8. Arch Intern Med. 2006;166(5):507–13.PubMedCrossRef

79.

Bray P, Thompson D, Wynn JD, Cummings DM, Whetstone L. Confronting disparities in diabetes care: the clinical effectiveness of redesigning care management for minority patients in rural primary care practices. J Rural Health Off J Am Rural Health Assoc Natl Rural Health Care Assoc. 2005;21(4):317–21.CrossRef

80.

Bray P, Roupe M, Young S, Harrell J, Cummings DM, Whetstone LM. Feasibility and effectiveness of system redesign for diabetes care management in rural areas: the eastern North Carolina experience. Diabetes Educ. 2005;31(5):712–8.PubMedCrossRef

81.

Fanning EL, Selwyn BJ, Larme AC, DeFronzo RA. Improving efficacy of diabetes management using treatment algorithms in a mainly Hispanic population. Diabetes Care. 2004;27(7):1638–46.PubMedCrossRef

82.

Gary TL, Batts-Turner M, Bone LR, Yeh H-C, Wang N-Y, Hill-Briggs F, et al. A randomized controlled trial of the effects of nurse case manager and community health worker team interventions in urban African-Americans with type 2 diabetes. Control Clin Trials. 2004;25(1):53–66.PubMedCrossRef

83.

Hopper SV, Miller JP, Birge C, Swift J. A randomized study of the impact of home health aides on diabetic control and utilization patterns. Am J Public Health. 1984;74(6):600–2.PubMedPubMedCentralCrossRef

84.

Hosler AS, Godley K, Rowland DH. An initiative to improve diabetes care standards in healthcare organizations serving minorities. Diabetes Educ. 2002;28(4):581–9.PubMedCrossRef

85.

Jaber LA, Halapy H, Fernet M, Tummalapalli S, Diwakaran H. Evaluation of a pharmaceutical care model on diabetes management. Ann Pharmacother. 1996;30(3):238–43.PubMed

86.

Miller CD, Barnes CS, Phillips LS, Ziemer DC, Gallina DL, Cook CB, et al. Rapid A1c availability improves clinical decision-making in an urban primary care clinic. Diabetes Care. 2003;26(4):1158–63.PubMedCrossRef

87.

Philis-Tsimikas A, Walker C, Rivard L, Talavera G, Reimann JOF, Salmon M, et al. Improvement in diabetes care of underinsured patients enrolled in project dulce: a community-based, culturally appropriate, nurse case management and peer education diabetes care model. Diabetes Care. 2004;27(1):110–5.PubMedCrossRef

88.

Cook CB, Penman A, Cobb AB, Miller D, Murphy T, Horn T. Outpatient diabetes management of medicare beneficiaries in four Mississippi fee-for-service primary care clinics. J Miss State Med Assoc. 1999;40(1):8–13.PubMed

89.

Mahotiere TJ. A program to reduce the disparity in the rate of biennial lipid profiles between African-American and white Medicare beneficiaries with diabetes mellitus in New York City. Health P. 2006;31(4 SRC - GoogleScholar):263–88.

90.

Gary TL, Batts-Turner M, Yeh H-C, Hill-Briggs F, Bone LR, Wang N-Y, et al. The effects of a nurse case manager and a community health worker team on diabetic control, emergency department visits, and hospitalizations among urban African Americans with type 2 diabetes mellitus: a randomized controlled trial. Arch Intern Med. 2009;169(19):1788–94.PubMedCrossRef

91.

Rith-Najarian S, Branchaud C, Beaulieu O, Gohdes D, Simonson G, Mazze R. Reducing lower-extremity amputations due to diabetes. Application of the staged diabetes management approach in a primary care setting. J Fam Pract. 1998;47(2):127–32.PubMed

92.

Ziemer DC, Tsui C, Caudle J, Barnes CS, Dames F, Phillips LS. An informatics-supported intervention improves diabetes control in a primary care setting. AMIA Annu Symp Proc AMIA Symp AMIA Symp. 2006:1160.

93.

American Diabetes Association. Standards of medical care in diabetes – 2014. Diabetes Care. 2014;37 Suppl 1:S14–80.CrossRef

94.

Estruch R, Ros E, Salas-Salvadó J, Covas M-I, Corella D, Arós F, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013;368(14):1279–90.PubMedCrossRef

95.

Esposito K, Maiorino MI, Ciotola M, Di Palo C, Scognamiglio P, Gicchino M, et al. Effects of a Mediterranean-style diet on the need for antihyperglycemic drug therapy in patients with newly diagnosed type 2 diabetes: a randomized trial. Ann Intern Med. 2009;151(5):306–14.PubMedCrossRef

96.

Elhayany A, Lustman A, Abel R, Attal-Singer J, Vinker S. A low carbohydrate Mediterranean diet improves cardiovascular risk factors and diabetes control among overweight patients with type 2 diabetes mellitus: a 1-year prospective randomized intervention study. Diabetes Obes Metab. 2010;12(3):204–9.PubMedCrossRef

97.

Abiemo EE, Alonso A, Nettleton JA, Steffen LM, Bertoni AG, Jain A, et al. Relationships of the Mediterranean dietary pattern with insulin resistance and diabetes incidence in the Multi-Ethnic Study of Atherosclerosis (MESA). Br J Nutr. 2013;109(08):1490–7.PubMedCrossRef

98.

Orlich MJ. Vegetarian dietary patterns and mortality in adventist health study 2. JAMA Intern Med. 2013;173(13):1230.PubMedPubMedCentralCrossRef

99.

Tonstad S, Butler T, Yan R, Fraser GE. Type of vegetarian diet, body weight, and prevalence of type 2 diabetes. Diabetes Care. 2009;32(5):791–6.PubMedPubMedCentralCrossRef

100.

Tonstad S, Stewart K, Oda K, Batech M, Herring RP, Fraser GE. Vegetarian diets and incidence of diabetes in the Adventist Health Study-2. Nutr Metab Cardiovasc Dis. 2013;23(4):292–9.PubMedCrossRef

101.

Barnard ND, Cohen J, Jenkins DJ, Turner-McGrievy G, Gloede L, Green A, et al. A low-fat vegan diet and a conventional diabetes diet in the treatment of type 2 diabetes: a randomized, controlled, 74-wk clinical trial. Am J Clin Nutr. 2009;89(5):1588S–96.PubMedPubMedCentralCrossRef

102.

Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, et al. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med. 1997;336(16):1117–24.PubMedCrossRef

103.

Shirani F, Salehi-Abargouei A, Azadbakht L. Effects of Dietary Approaches to Stop Hypertension (DASH) diet on some risk for developing type 2 diabetes: a systematic review and meta-analysis on controlled clinical trials. Nutrition. 2013;29(7-8):939–47.PubMedCrossRef

104.

Brand-Miller JC. Postprandial glycemia, glycemic index, and the prevention of type 2 diabetes. Am J Clin Nutr. 2004;80(2):243–4.PubMed

105.

Evert AB, Boucher JL, Cypress M, Dunbar SA, Franz MJ, Mayer-Davis EJ, et al. Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care. 2014;37(Supplement_1):S120–43.PubMedCrossRef

106.

Hu T, Mills KT, Yao L, Demanelis K, Eloustaz M, Yancy WS, et al. Effects of low-carbohydrate diets versus low-fat diets on metabolic risk factors: a meta-analysis of randomized controlled clinical trials. Am J Epidemiol. 2012;176 suppl 7:S44–54.PubMedPubMedCentralCrossRef

107.

Stern L, Iqbal N, Seshadri P, Chicano KL, Daily DA, McGrory J, et al. The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults: one-year follow-up of a randomized trial. Ann Intern Med. 2004;140(10):778–85.PubMedCrossRef

108.

Davis NJ, Tomuta N, Schechter C, Isasi CR, Segal-Isaacson CJ, Stein D, et al. Comparative study of the effects of a 1-year dietary intervention of a Low-carbohydrate diet versus a low-fat diet on weight and glycemic control in type 2 diabetes. Diabetes Care. 2009;32(7):1147–52.PubMedPubMedCentralCrossRef

109.

Boulé NG, Haddad E, Kenny GP, Wells GA, Sigal RJ. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA. 2001;286(10):1218.PubMedCrossRef

110.

Haddad E, Wells GA, Sigal RJ, Boulé NG, Kenny GP. Meta-analysis of the effect of structured exercise training on cardiorespiratory fitness in Type 2 diabetes mellitus. Diabetologia. 2003;46(8):1071–81.PubMedCrossRef

111.

Colberg SR, Sigal RJ, Fernhall B, Regensteiner JG, Blissmer BJ, Rubin RR, et al. Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement. Diabetes Care. 2010;33(12):e147–67.PubMedPubMedCentralCrossRef

112.

Boulé NG, Weisnagel SJ, Lakka TA, Tremblay A, Bergman RN, Rankinen T, et al. Effects of exercise training on glucose homeostasis: the HERITAGE Family Study. Diabetes Care. 2005;28(1):108–14.PubMedCrossRef

113.

Church TS, Blair SN, Cocreham S, Johannsen N, Johnson W, Kramer K, et al. Effects of aerobic and resistance training on hemoglobin A1c levels in patients with type 2 diabetes. JAMA J Am Med Assoc. 2010;304(20):2253.CrossRef

114.

Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med. 2004;350(7):664–71.PubMedPubMedCentralCrossRef

115.

Kelley DE, He J, Menshikova EV, Ritov VB. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes. 2002;51(10):2944–50.PubMedCrossRef

116.

Swift DL, Johannsen NM, Lavie CJ, Earnest CP, Johnson WD, Blair SN, et al. Racial differences in the response of cardiorespiratory fitness to aerobic exercise training in Caucasian and African American postmenopausal women. J Appl Physiol. 2013;114(10):1375–82.PubMedPubMedCentralCrossRef

117.

Santa-Clara H, Szymanski L, Ordille T, Fernhall B. Effects of exercise training on resting metabolic rate in postmenopausal African American and Caucasian women. Metabolism. 2006;55(10):1358–64.PubMedCrossRef

118.

Kokkinos P, Myers J, Nylen E, Panagiotakos DB, Manolis A, Pittaras A, et al. Exercise capacity and all-cause mortality in African American and Caucasian men with type 2 diabetes. Diabetes Care. 2009;32(4):623–8.PubMedPubMedCentralCrossRef

119.

Qiu S, Cai X, Chen X, Yang B, Sun Z. Step counter use in type 2 diabetes: a meta-analysis of randomized controlled trials. BMC Med. 2014;12(1):36.PubMedPubMedCentralCrossRef

120.

Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med. 2001;345(11):790–7.PubMedCrossRef

121.

Narayan KMV, Boyle JP, Thompson TJ, Gregg EW, Williamson DF. Effect of BMI on lifetime risk for diabetes in the U.S. Diabetes Care. 2007;30(6):1562–6.PubMedCrossRef

122.

Neeland IJ, Turer AT, Ayers MCR, Powell-Wiley TM, Vega GL, Farzaneh-Far R, et al. Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA J Am Med Assoc. 2012;308(11):1150.CrossRef

123.

Rabkin SW, Mathewson FA, Hsu P-H. Relation of body weight to development of ischemic heart disease in a cohort of young North American men after a 26 year observation period: the Manitoba Study. Am J Cardiol. 1977;39(3):452–8.PubMedCrossRef

124.

Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26- year follow-up of participants in the Framingham Heart Study. Circulation. 1983;67(5):968–77.PubMedCrossRef

125.

Wilson PWF, D’Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med. 2002;162(16):1867–72.PubMedCrossRef

126.

Di Angelantonio E, Kaptoge S, Wormser D, Willeit P, Butterworth AS, Bansal N, et al. Association of cardiometabolic multimorbidity with mortality. JAMA. 2015;314(1):52.PubMedCrossRef

127.

Després J-P, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444(7121):881–7.PubMedCrossRef

128.

Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444(7121):840–6.PubMedCrossRef

129.

Rosen ED, Spiegelman BM. Adipocytes as regulators of energy balance and glucose homeostasis. Nature. 2006;444(7121):847–53.PubMedPubMedCentralCrossRef

130.

Lau DCW. Adipokines: molecular links between obesity and atherosclerosis. AJP Heart Circ Physiol. 2005;288(5):H2031–41.CrossRef

131.

The Look AHEAD Research Group. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369(2):145–54.PubMedCentralCrossRef

132.

Lazo M, Solga SF, Horska A, Bonekamp S, Diehl AM, Brancati FL, et al. Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes. Diabetes Care. 2010;33(10):2156–63.PubMedPubMedCentralCrossRef

133.

Group LAR, et al. Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol. 2014;2(10):801–9.CrossRef

134.

Wing RR. Implications of Look AHEAD for clinical trials and clinical practice. Diabetes Obes Metab. 2014;16(12):1183–91.PubMedPubMedCentralCrossRef

135.

Foster GD, Wadden TA, LaGrotte CA, Vander Veur SS, Hesson LA, Homko CJ, et al. A randomized comparison of a commercially available portion-controlled weight-loss intervention with a diabetes self-management education program. Nutr Diabetes. 2013;3(3):e63.PubMedPubMedCentralCrossRef

136.

Pillay J, Armstrong MJ, Butalia S, Donovan LE, Sigal RJ, Vandermeer B, et al. Behavioral programs for type 2 diabetes mellitus: a systematic review and network meta-analysis. Ann Intern Med. 2015;163(11):848.PubMedCrossRef

137.

Malkani S. An update on the role of bariatric surgery in diabetes management. Curr Opin Endocrinol Diabetes Obes. 2015;22(2):98–105.PubMedCrossRef

138.

Vest AR, Heneghan HM, Schauer PR, Young JB. Surgical management of obesity and the relationship to cardiovascular disease. Circulation. 2013;127(8):945–59. doi: 10.1161/CIRCULATIONAHA.112.103275.

139.

Spaniolas K, Kasten KR, Brinkley J, Sippey ME, Mozer A, Chapman WH, et al. The changing bariatric surgery landscape in the USA. Obes Surg. 2015;25(8):1544–6.PubMedCrossRef

140.

Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724–37.PubMedCrossRef

141.

Tice JA, Karliner L, Walsh J, Petersen AJ, Feldman MD. Gastric banding or bypass? A systematic review comparing the two most popular bariatric procedures. Am J Med. 2008;121(10):885–93.PubMedCrossRef

142.

Trastulli S, Desiderio J, Guarino S, Cirocchi R, Scalercio V, Noya G, et al. Laparoscopic sleeve gastrectomy compared with other bariatric surgical procedures: a systematic review of randomized trials. Surg Obes Relat Dis. 2013;9(5):816–29.PubMedCrossRef

143.

Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Brethauer SA, Navaneethan SD, et al. Bariatric surgery versus intensive medical therapy for diabetes—3-year outcomes. N Engl J Med. 2014;370(21):2002–13.PubMedCrossRef

144.

Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366(17):1567–76.PubMedPubMedCentralCrossRef

145.

Kashyap SR, Bhatt DL, Wolski K, Watanabe RM, Abdul-Ghani M, Abood B, et al. Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment. Diabetes Care. 2013;36(8):2175–82.PubMedPubMedCentralCrossRef

146.

Adams TD, Davidson LE, Litwin SE, Kolotkin RL, LaMonte MJ, Pendleton RC, et al. Health benefits of gastric bypass surgery after 6 years. JAMA. 2012;308(11):1122.PubMedPubMedCentralCrossRef

147.

Courcoulas AP. Weight change and health outcomes at 3 years after bariatric surgery among individuals with severe obesity. JAMA [Internet]. 2013 [cited 5 Dec 2015]. Available from: http://jama.jamanetwork.com/article.aspx?. doi:10.1001/jama.2013.280928.

148.

Courcoulas AP, Goodpaster BH, Eagleton JK, Belle SH, Kalarchian MA, Lang W, et al. Surgical vs medical treatments for type 2 diabetes mellitus: a randomized clinical trial. JAMA Surg. 2014;149(7):707.PubMedPubMedCentralCrossRef

149.

Ng J, Seip R, Stone A, Ruano G, Tishler D, Papasavas P. Ethnic variation in weight loss, but not co-morbidity remission, after laparoscopic gastric banding and Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2015;11(1):94–100.PubMedCrossRef

150.

Ikramuddin S, Korner J, Lee W-J, Connett JE, Inabnet WB, Billington CJ, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension and hyperlipidemia. JAMA. 2013;309(21):2240–9.PubMedPubMedCentralCrossRef

151.

Hutter MM, Schirmer BD, Jones DB, Ko CY, Cohen ME, Merkow RP, et al. First Report from the American College of Surgeons Bariatric Surgery Center Network: laparoscopic sleeve gastrectomy has morbidity and effectiveness positioned between the band and the bypass. Ann Surg. 2011;254(3):410–22.PubMedPubMedCentralCrossRef

152.

Still CD, Wood GC, Benotti P, Petrick AT, Gabrielsen J, Strodel WE, et al. Preoperative prediction of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a retrospective cohort study. Lancet Diabetes Endocrinol. 2014;2(1):38–45.PubMedPubMedCentralCrossRef

153.

Maggard-Gibbons M, Maglione M, Livhits M, Ewing B, Maher AR, Hu J, et al. Bariatric surgery for weight loss and glycemic control in nonmorbidly obese adults with diabetes. JAMA. 2013;309(21):2250–61.PubMedCrossRef

154.

Parikh M, Issa R, Vieira D, McMacken M, Saunders JK, Ude-Welcome A, et al. Role of bariatric surgery as treatment for type 2 diabetes in patients who do not meet current NIH criteria: a systematic review and meta-analysis. J Am Coll Surg. 2013;217(3):527–32.PubMedCrossRef

155.

American Diabetes Association. Standards of medical care in diabetes – 2015. Diabetes Care. 2015;38(Supplement_1):S1–2.CrossRef

156.

Lee CJ, Clark JM, Schweitzer M, Magnuson T, Steele K, Koerner O, et al. Prevalence of and risk factors for hypoglycemic symptoms after gastric bypass and sleeve gastrectomy: postsurgical hypoglycemic symptoms. Obesity. 2015;23(5):1079–84.PubMedPubMedCentralCrossRef

157.

Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamond WD, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357(8):753–61.PubMedCrossRef

158.

Sjöström L, Narbro K, Sjöström CD, Karason K, Larsson B, Wedel H, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741–52.PubMedCrossRef

159.

Khorgami Z, Arheart KL, Zhang C, Messiah SE, de la Cruz-Muñoz N. Effect of ethnicity on weight loss after bariatric surgery. Obes Surg. 2015;25(5):769–76.PubMedCrossRef

160.

Coleman KJ, Huang Y-C, Koebnick C, Reynolds K, Xiang AH, Black MH, et al. Metabolic syndrome is less likely to resolve in hispanics and non-hispanic blacks after bariatric surgery. Ann Surg. 2014;259(2):279–85.PubMedCrossRef

161.

Yasuda S, Zhang L, Huang S-M. The role of ethnicity in variability in response to drugs: focus on clinical pharmacology studies. Clin Pharmacol Ther. 2008;84(3):417–23. 38.PubMedCrossRef

162.

Pearson ER, Starkey BJ, Powell RJ, Gribble FM, Clark PM, Hattersley AT. Genetic cause of hyperglycaemia and response to treatment in diabetes. Lancet Lond Engl. 2003;362(9392):1275–81.CrossRef

163.

Fajans SS, Bell GI. MODY: history, genetics, pathophysiology, and clinical decision making. Diabetes Care. 2011;34(8):1878–84.PubMedPubMedCentralCrossRef

164.

García-Martín E, Martínez C, Ladero JM, Agúndez JA. Interethnic and intraethnic variability of CYP2C8 and CYP2C9 polymorphisms in healthy individuals. Mol Diagn Ther. 2006;10(1):29–40.PubMedCrossRef

165.

Williams LK, Padhukasahasram B, Ahmedani BK, Peterson EL, Wells KE, González Burchard E, et al. Differing effects of metformin on glycemic control by race-ethnicity. J Clin Endocrinol Metab. 2014;99(9):3160–8.PubMedPubMedCentralCrossRef

166.

Gosmanova EO, MANGOLD TA, RAWLS WN, WALL BM, et al. Effect of metformin-containing antidiabetic regimens on all-cause mortality in veterans with type 2 diabetes mellitus. Am J Med Sci. 2008;336(3):241–7.PubMedCrossRef

167.

Ford ES. Trends in the control of risk factors for cardiovascular disease among adults with diagnosed diabetes: findings from the National Health and Nutrition Examination Survey 1999–2008*: cardiovascular risk factor control. J Diabetes. 2011;3(4):337–47.PubMedCrossRef

168.

Lackland DT. Racial differences in hypertension: implications for high blood pressure management. Am J Med Sci. 2014;348(2):135–8.PubMedPubMedCentralCrossRef

169.

Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008. JAMA. 2010;303(20):2043–50.PubMedCrossRef

170.

Guo F, He D, Zhang W, Walton RG. Trends in prevalence, awareness, management, and control of hypertension among United States adults, 1999 to 2010. J Am Coll Cardiol. 2012;60(7):599–606.PubMedCrossRef

171.

Oliva RV, Bakris GL. Blood pressure effects of sodium–glucose co-transport 2 (SGLT2) inhibitors. J Am Soc Hypertens. 2014;8(5):330–9.PubMedCrossRef

172.

Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA. 2014;311(8):806.PubMedPubMedCentralCrossRef

173.

Buse JB, Rosenstock J, Sesti G, Schmidt WE, Montanya E, Brett JH, et al. Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6). Lancet. 2009;374(9683):39–47.PubMedCrossRef

174.

Wang B, Zhong J, Lin H, Zhao Z, Yan Z, He H, et al. Blood pressure-lowering effects of GLP-1 receptor agonists exenatide and liraglutide: a meta-analysis of clinical trials. Diabetes Obes Metab. 2013;15(8):737–49.PubMedCrossRef

175.

Ferdinand KC, Nasser SA. Racial/ethnic disparities in prevalence and care of patients with type 2 diabetes mellitus. Curr Med Res Opin. 2015;31(5):913–23.PubMedCrossRef

176.

Xia Y, Kelton CML, Guo JJ, Bian B, Heaton PC. Treatment of obesity: pharmacotherapy trends in the United States from 1999 to 2010: pharmacotherapy treatment of obesity. Obesity. 2015;23(8):1721–8.PubMedCrossRef

177.

Khan LK, Serdula MK, Bowman BA, Williamson DF. Use of prescription weight loss pills among US adults in 1996–1998. Ann Intern Med. 2001;134(4):282–6.PubMedCrossRef

178.

Apovian CM, Aronne LJ, Bessesen DH, McDonnell ME, Murad MH, Pagotto U, et al. Pharmacological management of obesity: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(2):342–62.PubMedCrossRef

179.

Zhuo X, Zhang P, Barker L, Albright A, Thompson TJ, Gregg E. The lifetime cost of diabetes and its implications for diabetes prevention. Diabetes Care. 2014;37(9):2557–64.PubMedCrossRef

180.

The Diabetes Prevention Program. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403.CrossRef

181.

Pan X-R, Li G, Hu Y-H, Wang J-X, Yang W-Y, An Z-X, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20(4):537–44.PubMedCrossRef

182.

Delahanty LM, Pan Q, Jablonski KA, Aroda VR, Watson KE, Bray GA, et al. Effects of weight loss, weight cycling, and weight loss maintenance on diabetes incidence and change in cardiometabolic traits in the diabetes prevention program. Diabetes Care. 2014;37(10):2738–45.PubMedPubMedCentralCrossRef

183.

Diabetes Prevention Program Resea. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374(9702):1677–86.CrossRef

184.

Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. Lancet Diabetes Endocrinol [Internet]. 2015 Sep [cited 2015 Oct 7]; Available from: http://linkinghub.elsevier.com/retrieve/pii/S2213858715002910

185.

Ali MK, Echouffo-Tcheugui JB, Williamson DF. How effective were lifestyle interventions in real-world settings that were modeled on the diabetes prevention program? Health Aff (Millwood). 2012;31(1):67–75.CrossRef

186.

Kahn R, Davidson MB. The reality of type 2 diabetes prevention. Diabetes Care. 2014;37(4):943–9.PubMedPubMedCentralCrossRef

187.

Samuel-Hodge CD, Johnson CM, Braxton DF, Lackey M. Effectiveness of diabetes prevention program translations among African Americans: African Americans and DPP translations. Obes Rev. 2014;15:107–24.PubMedCrossRef

188.

Ackermann RT, Liss DT, Finch EA, Schmidt KK, Hays LM, Marrero DG, et al. A randomized comparative effectiveness trial for preventing type 2 diabetes. Am J Public Health. 2015;105(11):2328–34.PubMedPubMedCentralCrossRef

189.

Katula JA, Vitolins MZ, Morgan TM, Lawlor MS, Blackwell CS, Isom SP, et al. The healthy living partnerships to prevent diabetes study. Am J Prev Med. 2013;44(4):S324–32.PubMedPubMedCentralCrossRef

190.

Faridi Z, Shuval K, Njike VY, Katz JA, Jennings G, Williams M, et al. Partners reducing effects of diabetes (PREDICT): a diabetes prevention physical activity and dietary intervention through African-American churches. Health Educ Res. 2010;25(2):306–15.PubMedCrossRef

191.

Parikh P, Simon EP, Fei K, Looker H, Goytia C, Horowitz CR. Results of a pilot diabetes prevention intervention in East Harlem, New York City: project HEED. Am J Public Health. 2010;100 Suppl 1:S232–9.PubMedPubMedCentralCrossRef

192.

Perez A, Alos VA, Scanlan A, Maia CM, Davey A, Whitaker RC, et al. The rationale, design, and baseline characteristics of PREVENT-DM: a community-based comparative effectiveness trial of lifestyle intervention and metformin among Latinas with prediabetes. Contemp Clin Trials. 2015;45:320–7.PubMedPubMedCentralCrossRef

193.

Jiang L, Manson SM, Beals J, Henderson WG, Huang H, Acton KJ, et al. Translating the diabetes prevention program into American Indian and Alaska native communities: results from the special diabetes program for Indians diabetes prevention demonstration project. Diabetes Care. 2013;36(7):2027–34.PubMedPubMedCentralCrossRef

194.

Kaholokula JK, Wilson RE, Townsend CKM, Zhang GX, Chen J, Yoshimura SR, et al. Translating the diabetes prevention program in native Hawaiian and pacific islander communities: the PILI ‘ohana project. Transl Behav Med. 2014;4(2):149–59.PubMedCrossRef

195.

Islam N, Zanowiak J, Wyatt L, Kavathe R, Singh H, Kwon S, et al. Diabetes prevention in the New York City Sikh Asian Indian community: a pilot study. Int J Environ Res Public Health. 2014;11(5):5462–86.PubMedPubMedCentralCrossRef

196.

Leake AR, Bermudo VC, Jacob J, Jacob MR, Inouye J. Health is wealth: methods to improve attendance in a lifestyle intervention for a largely immigrant Filipino-American sample. J Immigr Minor Health. 2012;14(3):475–80.PubMedCrossRef

197.

Islam NS, Zanowiak JM, Wyatt LC, Chun K, Lee L, Kwon SC, et al. A randomized-controlled, pilot intervention on diabetes prevention and healthy lifestyles in the New York City Korean community. J Community Health. 2013;38(6):1030–41.PubMedPubMedCentralCrossRef

198.

Dunkley AJ, Bodicoat DH, Greaves CJ, Russell C, Yates T, Davies MJ, et al. Diabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline recommendations: a systematic review and meta-analysis. Diabetes Care. 2014;37(4):922–33.PubMedCrossRef

199.

Chou C-H, Burnet D, Meltzer D, Huang E. The effectiveness of diabetes prevention programs in community settings [Internet]. 2015 [cited 15 Dec 2015]. Available from: http://198.246.124.29/diabetes/pdfs/data/2014-report-acknowledgments.pdf.

200.

Knowler WC, Ackermann RT. Preventing diabetes in American Indian communities. Diabetes Care. 2013;36(7):1820–2.PubMedPubMedCentralCrossRef

201.

Gaede P, Vedel P, Larsen N, Jensen GV, Parving H-H, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348(5):383–93.PubMedCrossRef

202.

Moore SH, Martin DP, Richardson WC. Does the primary-care gatekeeper control the costs of health care? Lessons from the SAFECO experience. N Engl J Med. 1983;309(22):1400–4.PubMedCrossRef

203.

de Sonnaville JJ, Bouma M, Colly LP, Devillé W, Wijkel D, Heine RJ. Sustained good glycaemic control in NIDDM patients by implementation of structured care in general practice: 2-year follow-up study. Diabetologia. 1997;40(11):1334–40.PubMedCrossRef

204.

Hirsch IB, Goldberg HI, Ellsworth A, Evans TC, Herter CD, Ramsey SD, et al. A multifaceted intervention in support of diabetes treatment guidelines: a cont trial. Diabetes Res Clin Pract. 2002;58(1):27–36.PubMedCrossRef

205.

Legorreta A, Peters A, Ossorio C, Lopez RJ, Jatulis D, Davidson MB. Effect of a comprehensive nurse-managed diabetes program: an HMO prospective study. Am J Manag Care. 1996;2:1024–30.

206.

Sadur CN, Moline N, Costa M, Michalik D, Mendlowitz D, Roller S, et al. Diabetes management in a health maintenance organization. Efficacy of care management using cluster visits. Diabetes Care. 1999;22(12):2011–7.PubMedCrossRef

207.

Majumdar SR, Guirguis LM, Toth EL, Lewanczuk RZ, Lee TK, Johnson JA. Controlled trial of a multifaceted intervention for improving quality of care for rural patients with type 2 diabetes. Diabetes Care. 2003;26(11):3061–6.PubMedCrossRef

208.

California Medi-Cal Type 2 Diabetes Study Group. Closing the gap: effect of diabetes case management on glycemic control among low-income ethnic minority populations: the California Medi-Cal type 2 diabetes study. Diabetes Care. 2004;27(1):95–103.CrossRef

209.

Polonsky WH, Earles J, Smith S, Pease DJ, Macmillan M, Christensen R, et al. Integrating medical management with diabetes self-management training: a randomized control trial of the Diabetes Outpatient Intensive Treatment program. Diabetes Care. 2003;26(11):3048–53.PubMedCrossRef

210.

Gaede P, Lund-Andersen H, Parving H-H, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358(6):580–91.PubMedCrossRef

211.

Shea S, Weinstock RS, Starren J, Teresi J, Palmas W, Field L, et al. A randomized trial comparing telemedicine case management with usual care in older, ethnically diverse, medically underserved patients with diabetes mellitus. J Am Med Inform Assoc. 2006;13(1):40–51.PubMedPubMedCentralCrossRef

212.

Ko S-H, Song K-H, Kim S-R, Lee J-M, Kim J-S, Shin J-H, et al. Long-term effects of a structured intensive diabetes education programme (SIDEP) in patients with Type 2 diabetes mellitus – a 4-year follow-up study. Diabet Med J Br Diabet Assoc. 2007;24(1):55–62.CrossRef

213.

Chin MH, Zhang JX, Merrell K. Specialty differences in the care of older patients with diabetes. Med Care. 2000;38(2):131–40.PubMedCrossRef

214.

Martin DP, Diehr P, Price KF, Richardson WC. Effect of a gatekeeper plan on health services use and charges: a randomized trial. Am J Public Health. 1989;79(12):1628–32.PubMedPubMedCentralCrossRef

215.

Kivimäki M, Virtanen M, Kawachi I, Nyberg ST, Alfredsson L, Batty GD, et al. Long working hours, socioeconomic status, and the risk of incident type 2 diabetes: a meta-analysis of published and unpublished data from 222 120 individuals. Lancet Diabetes Endocrinol. 2015;3(1):27–34.PubMedPubMedCentralCrossRef

216.

McKenzie B. Modes less traveled—bicycling and walking to work in the United States: 2008–2012. US Census Bur N Y [Internet]. 2014 [cited 15 Dec 2015]. Available from: https://www.census.gov/content/dam/Census/library/publications/2014/acs/acs-25.pdf.

217.

Lachat C, Nago E, Verstraeten R, Roberfroid D, Van Camp J, Kolsteren P. Eating out of home and its association with dietary intake: a systematic review of the evidence: eating out and diet. Obes Rev. 2012;13(4):329–46.PubMedCrossRef

218.

Moore LV, Diez Roux AV, Nettleton JA, Jacobs DR, Franco M. Fast-food consumption, diet quality, and neighborhood exposure to fast food: the multi-ethnic study of atherosclerosis. Am J Epidemiol. 2009;170(1):29–36.PubMedPubMedCentralCrossRef

219.

Roux AVD, Smith AE, Gore LD. Associations of fast food restaurant availability with dietary intake and weight among African Americans in the Jackson heart study, 2000–2004. Am J Public Health. 2011;101(S1):S301.CrossRef

220.

Block JP, Scribner RA, DeSalvo KB. Fast food, race/ethnicity, and income. Am J Prev Med. 2004;27(3):211–7.PubMed

221.

Hicks RA, Lucero-Gorman K, Bautista J, HICKS GJ. Ethnicity, sleep duration, and sleep satisfaction. Percept Mot Skills. 1999;88(1):234–5.PubMedCrossRef

222.

Lauderdale DS. Objectively measured sleep characteristics among early-middle-aged adults: the CARDIA study. Am J Epidemiol. 2006;164(1):5–16.PubMedCrossRef

223.

Gangwisch JE, Heymsfield SB, Boden-Albala B, Buijs RM, Kreier F, Pickering TG, et al. Sleep duration as a risk factor for diabetes incidence in a large US sample. Sleep. 2007;30(12):1667.PubMedPubMedCentral

224.

Buxton OM, Pavlova M, Reid EW, Wang W, Simonson DC, Adler GK. Sleep restriction for 1 week reduces insulin sensitivity in healthy men. Diabetes. 2010;59(9):2126–33.PubMedPubMedCentralCrossRef

225.

Broussard JL, Ehrmann DA, Van Cauter E, Tasali E, Brady MJ. Impaired insulin signaling in human adipocytes after experimental sleep restriction A randomized, crossover study. Ann Intern Med. 2012;157(8):549–57.PubMedPubMedCentralCrossRef

226.

Cappuccio FP, D’Elia L, Strazzullo P, Miller MA. Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2009;33(2):414–20.PubMedPubMedCentralCrossRef

227.

Knutson KL, Ryden AM, Mander BA, Van Cauter E. Role of sleep duration and quality in the risk and severity of type 2 diabetes mellitus. Arch Intern Med. 2006;166(16):1768.PubMedCrossRef

228.

Beihl DA, Liese AD, Haffner SM. Sleep duration as a risk factor for incident type 2 diabetes in a multiethnic cohort. Ann Epidemiol. 2009;19(5):351–7.PubMedCrossRef

229.

Matthews CE, Chen KY, Freedson PS, Buchowski MS, Beech BM, Pate RR, et al. Amount of time spent in sedentary behaviors in the United States, 2003–2004. Am J Epidemiol. 2008;167(7):875–81.PubMedPubMedCentralCrossRef

230.

Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness. JAMA. 2002;288(14):1775–9.PubMedCrossRef

Be confident that your patient care is up to date

Medicine Matters is being incorporated into Springer Medicine, our new medical education platform.

Alongside the news coverage and expert commentary you have come to expect from Medicine Matters diabetes, Springer Medicine's complimentary membership also provides access to articles from renowned journals and a broad range of Continuing Medical Education programs. Create your free account »

Medicine Matters Diabetes

Abstract

Be confident that your patient care is up to date